TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Adherence scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: time required to create retroperitoneal space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall costs to create retroperitoneal space
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HIV transmissions between communities
Endpoint domain: Mortality/survival
Primary endpoint: Overall success rate of subclavian catheter placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: health-related quality of life related to emotional functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tactile acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ICAM-1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Theory of Mind (ToM) improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Executive Function (EF) improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in dementia knowledge, attitudes, competence, and empathy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: tooth inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transverse skeletal increase of the maxilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate or fast TD progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pointwise PD rates categorized as moderate or fast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biochemically validated ≥50% smoking reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported ≥50% smoking reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to worsening in global health status/QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of improvement in global health status/QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Confidence in Communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short-term recovery of functional ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Nasal Symptom Scores (TNSS) Peak0-1h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Nasal Symptom Scores (TNSS) AUC0-1h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rod expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual pelvic obliquity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in relative abundance of bacterial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NSAIDs consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full recovery rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Colonoscopy scheduling rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive and attention skills improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: IBDQ response
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IBDQ remission
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FHV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trust in science
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pulmonary competence (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time 2 social communication skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to intervention drink
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: objectively measured adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PSEQ improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of regular medical check-ups for part-time employees
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficacy end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effective rate of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Indexes of UTP and UACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: CKMB concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breathlessness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: chest symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: respiratory muscle strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PD (probing depth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diet quality (Healthy Eating Index)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: individual-level percentage adherence over the two-month intensive phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum smear conversion following the standard two-month intensive phase treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in heart rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6-week response rate difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between ISQ and IT at implant insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxycodone rescue consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery (QoR) 15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: aggregated performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength (MVC-ISO and MVC-ECC torque)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 2-hour post-challenge glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DCS total scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of new metastatic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Effective communication skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy (GSE scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-regulated learning skills (SRLSS scores)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: blood flow in flexor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PROMIS-Fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total seizure rate decrement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Promotion of breast cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: ICOAP constant pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health assessment skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health workers' fidelity to the intervention protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the psychosocial intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall proficiency scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in the intensity of worst breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire to use dextroamphetamine for work
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desire to use dextroamphetamine for recreation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Communication Frequency (CF)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Overall TEAM score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Children's risk-taking outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long half-life of eliapixant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC[0-inf])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-min hall walk (6MHW) distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minnesota Living With Heart Failure (MLWHF) QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: New York Heart Association (NYHA) class improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate timing of toothbrushing
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Awareness of the importance of adequate toothbrushing frequency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adequate toothbrushing frequency
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Use of fluoride toothpaste
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fast-pace 5- and 10-step stair ascent power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected Visual Acuity (VA) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean sphere improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Steeper Keratometry improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of titanium disc area covered by residual biofilm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FIT completion rate at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption rate (ka)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concomitant improvement on cognition and independent functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for DW-7202 over AST-120
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient adherence improvement after switching to DW-7202
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of severe acidosis
Endpoint domain: Adverse events/effects
Primary endpoint: Disease awareness rate
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean score of SQOL-F and PSRI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postprocedural atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6-month cigarette abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased lean muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improved markers of hepatic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: UDI-6 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bothersome stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urgency incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of FGF‐2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of VEGF‐A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of proteinuria
Endpoint domain: Adverse events/effects
Primary endpoint: 10-year all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Negative Oral Food Challenge (OFC) rates
Endpoint domain: Adverse events/effects
Primary endpoint: Cow's milk-specific IgE level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adrenaline requirement rates
Endpoint domain: Adverse events/effects
Primary endpoint: Reduced cesarean rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced neonatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score for pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CV/mortality outcomes
Endpoint domain: Mortality/survival
Primary endpoint: moderate-to-severe hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: falls or fractures
Endpoint domain: Adverse events/effects
Primary endpoint: Social distancing adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage change from baseline in the Severity of Alopecia Tool score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in morning pre-dose trough FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in RBANS scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Elevation of liver enzymes (ALT/AST)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical remission of complex perianal fistulas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rate of tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: average total smoking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of puffs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-session subjective experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: median overall alignment duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support for moving a POP OTC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First postoperative flatus time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: First postoperative defecation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CRP levels on postoperative days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LnRMSSD increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: conspicuous pore number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: wrinkle count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum LPS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive changes in mindfulness facets
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event rate of procedure-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Need for secondary BPH therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean reduction in HRSD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in SDS scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: time for completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to first moderate or severe AECOPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 2-point static test on the chin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 2-point static test on the lip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: direction test on the chin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC for predicting EGFR mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binding-antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum neutralizing activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCP-1 plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calf circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fractional exhaled NO (FeNO) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion preferring screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recent HIV infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: sensitivity and specificity for MCI screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of subsequent VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: intraoperative cumulative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cormack-Lehane grade I glottis view rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of morphine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Heart Failure Hospitalization (HHF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular Mortality (CVM)
Endpoint domain: Mortality/survival
Primary endpoint: Major adverse cardiovascular events (MACE) at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: TNSMS reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care preferences after discharge
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Improvement in theoretical scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mastery of operational skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: positive emotions related to depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of depressive symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MWT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median percent change in weight from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with weight loss ≥5% relative to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal voluntary isometric contraction (MVIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1RM leg extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1RM chest press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age at diagnosis of clinically significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: academic growth to post test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in supporting patient individuality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in maintaining patient individuality while providing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rorα levels in muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apoC-III levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes